IMPACT
Autogene will potentially de-risk healthcare providers by minimizing their exposure to infectious bacteria. The AutoGene test has demonstrated more than 90% diagnostic accuracy in lab settings which will be further validated in real world settings. At one third the cost of comparable tests, Autogene has the potential for widespread use in primary care settings around the world.
“The core idea was to make the best healthcare technologies accessible to everyone and we started from diagnostics. India is highly burdened with infectious diseases like typhoid and tuberculosis which cause high mortality and morbidity every year. A major number of these diseases come from underprivileged locations so there is a need for technology that can reach such locations and also cost-effective.” –
Saurabh Singh, Co-founder, Valetude Primus Healthcare